Well, if you needed any further proof that unchecked capitalism and health care are a toxic combo after Steven Brill’s exposé a few years back, add Mylan’s EpiPen price increase to the list of thousands of examples. Mylan joins Turing Pharmaceuticals and a host of other big pharma villains to dramatically increase the price of life-saving drugs, with no justifiable cause other than that they have a monopoly and can get away with it. Since 2009, EpiPen prices have increased from under $100 per 2-pack to over $600 in the U.S. market (despite staying at below $100 elsewhere, such as...
[Read the rest of the story at 20somethingfinance.com]
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
[Read the rest of the story at 20somethingfinance.com]